Thymosin Beta-4 (Full Chain 43aa)

Human clinical Healing & Recovery In 1 protocol 3 sources

Thymosin Beta-4 is a naturally occurring 43-amino acid peptide that plays a vital role in tissue repair, cell migration, and inflammation reduction. Research highlights its ability to promote angiogenesis and wound healing, making it a subject of study for cardiovascular repair, corneal healing, and muscle recovery.

01Dosing reference

Amount

2-5 mg per dose

Frequency

2-3 times per week

Cycle

4-6 weeks on, followed by 2-4 weeks off

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Actin Sequestration

TB-4 binds to G-actin, preventing its polymerization into F-actin, which regulates the cellular cytoskeleton.

Cell Migration and Angiogenesis

By modulating actin dynamics, it promotes the migration of endothelial cells and keratinocytes, and stimulates the formation of new blood vessels.

Tissue Repair and Anti-inflammation

These cellular actions accelerate wound closure, reduce inflammatory cytokines, and protect tissues from apoptosis and oxidative damage.

03Human evidence

Improved healing in patients with neurotrophic keratitis and dry eye syndrome.

Phase 2 and Phase 3 clinical trials using topical TB-4 eye drops showed significant improvements in corneal healing and symptom reduction.

Safety and tolerability in dermal wound healing.

Phase 2 trials for pressure ulcers and venous stasis ulcers demonstrated that topical application was well-tolerated, though efficacy results were mixed depending on the wound type.

04Preclinical evidence

Enhanced cardiac repair post-myocardial infarction.

Mouse models showed that TB-4 administration after a heart attack promoted survival of cardiomyocytes and stimulated angiogenesis, reducing scar size.

Accelerated skeletal muscle regeneration.

Animal studies demonstrated that TB-4 increases the migration of myoblasts to sites of muscle injury, speeding up the repair process.

05What is known vs. unknown

Reasonably established

Acts as a major actin-sequestering protein in mammalian cells.
Promotes angiogenesis (new blood vessel formation) essential for tissue repair.
Demonstrates anti-inflammatory and anti-apoptotic properties in various tissue models.
Has been studied in human clinical trials primarily for ophthalmic and dermal conditions.

Unknowns & limits

Long-term safety of systemic administration in humans remains insufficiently documented.
Optimal dosing protocols for systemic tissue repair (e.g., muscle or cardiac recovery) in humans are not fully established.
Potential risks regarding its role in cell proliferation and cancer progression require further long-term investigation.

06Safety & regulatory context

Regulatory statusThymosin Beta-4 is generally well-tolerated in clinical trials, particularly in topical formulations for eye and skin conditions. However, systemic use (such as subcutaneous injections) lacks extensive long-term human safety data. Because it promotes cell migration and angiogenesis, there are theoretical concerns about its potential to exacerbate existing cancers, though it is not considered a carcinogen. It is not FDA-approved for systemic use and is often classified as an investigational or research chemical. Furthermore, it is banned by the World Anti-Doping Agency (WADA) for use in competitive sports.

07Compared with TB-500 (Thymosin Beta-4 Fragment)

Thymosin Beta-4 (Full Chain 43aa) vs. TB-500 (Thymosin Beta-4 Fragment)

Key difference

TB-500 is typically a synthetic fragment (often the active domain, such as the 17-23 amino acid sequence) of the full 43-amino acid Thymosin Beta-4, designed for easier synthesis and potentially different pharmacokinetics.

When researchers discuss each

Researchers discuss full-chain TB-4 when studying the complete natural biological functions and in formal clinical trials (like eye drops), whereas TB-500 is often discussed in veterinary medicine (e.g., equine sports) and informal research contexts for systemic recovery.

08Appears in protocols

👁️ Thymosin Beta-4 Full Chain Protocol

2 mg (20 units) per injection, 2x/week2x/week (Mon & Thu)

09Glossary

Actin

A protein that forms the contractile filaments of muscle cells and is involved in motion and cellular structure.

Angiogenesis

The physiological process through which new blood vessels form from pre-existing vessels.

Apoptosis

The process of programmed cell death that occurs in multicellular organisms.

10Knowledge check

Q1What is the primary cellular mechanism by which Thymosin Beta-4 regulates the cytoskeleton?

Q2Which of the following is a theoretical concern regarding the systemic use of Thymosin Beta-4?

Q3Which interpretation best reflects the dossier’s documented limitation regarding systemic use of Thymosin Beta-4 in humans?

Q4According to the dossier, how is TB-500 (a fragment) typically contrasted with full-chain Thymosin Beta-4 in research context?

Q5Which safety or regulatory statement is supported by the dossier about Thymosin Beta-4?

11Sources

More in Healing & Recovery

See all

BPC-157

Healing & Recovery

Early human

BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.

250-500 mcg

TB-500 (Thymosin Beta-4)

Healing & Recovery

Early human

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.

2.0 - 2.5 mg per injection

KPV

Healing & Recovery

Early human

KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.

200-500 mcg/day

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.